Rada, Anna
Birnbacher, Robert
Gobbi, Claudio http://orcid.org/0000-0002-7554-0664
Kurthen, Martin
Ludolph, Albert
Naumann, Markus
Neirich, Ulrike
von Oertzen, Tim J. http://orcid.org/0000-0003-2164-7842
Ransmayr, Gerhard
Riepe, Matthias
Schimmel, Mareike
Schwartz, Oliver
Surges, Rainer http://orcid.org/0000-0002-3177-8582
Bien, Christian G. http://orcid.org/0000-0003-2225-8654
Funding for this research was provided by:
v. Bodelschwinghsche Stiftungen Bethel
Article History
Received: 2 August 2020
Revised: 25 September 2020
Accepted: 28 September 2020
First Online: 6 October 2020
Compliance with ethical standards
:
: Dr Bien obtained honoraria for speaking engagements from UCB (Monheim, Germany) and Desitin (Hamburg, Germany). He receives research support from the Deutsche Forschungsgemeinschaft (German Research Council, Bonn, Germany) and Gerd-Altenhof-Stiftung (Deutsches Stiftungs-Zentrum, Essen, Germany). Dr Gobbi reports that the Employer of the Department of Neurology, Neurocenter of Southern Switzerland (NSI), 6900 Lugano, Switzerland receives financial support from Biogen Idec, Celgene, Sanofi, Merck Serono, Novartis Roche, and Teva. The submitted work is not related to these agreements. Dr von Oertzen reports grants, personal fees, and non-financial support from Novartis Pharma, personal fees from Roche Pharma, personal fees from Biogen Idec Austria, personal fees from Liva Nova, grants from Grossegger & Drbal GmbH, grants from Merck, personal fees from Indivior Austria GmbH, personal fees and non-financial support from gtec GmbH Austria, personal fees and non-financial support from Boehringer-Ingelheim, personal fees from Philips, personal fees and non-financial support from UCB Pharma, personal fees from Almirall, personal fees from Eisai, outside the submitted work; and he is web editor in chief of the European Academy of Neurology (EAN), co-chair of the EAN scientific panel for epilepsy, and vice-president of the Österreichische Gesellschaft für Epileptologie (Austrian ILAE chapter). Dr Surges has received fees as a consultant from Bial, Desitin, Eisai, Liva Nova, Novartis, and UCB Pharma. He currently receives research support from the Federal Ministry of Health. Dr. Bien obtained honoraria for speaking engagements from UCB (Monheim, Germany), Desitin (Hamburg, Germany), and Euroimmun (Lübeck, Germany). He receives research support from Deutsche Forschungsgemeinschaft (German Research Council, Bonn, Germany) and Gerd-Altenhof-Stiftung (Deutsches Stiftungs-Zentrum, Essen, Germany). The other authors did not declare any conflict.
: This study was approved by the Ethics Committee of the University of Münster, Germany (2018-436-f-S).
: Since this was a retrospective analysis of data from the authors’ own clinical practice, patients’ consent was not required.
: Since this was a retrospective analysis of data from the authors’ own clinical practice, patients’ consent was not required.